Related Experiment Video
Updated: Jul 17, 2026
28:15
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis
1Department of Medicine and Pathology, State University of New York, Stony Brook.
Gastroenterology
|June 1, 1992
Summary
Ras mutations in colonic epithelium may serve as molecular markers for high-grade dysplasia and invasive cancer in chronic ulcerative colitis patients. Detecting these c-Ki-ras mutations aids in mapping disease progression.
Area of Science:
- Gastroenterology
- Molecular Biology
- Oncology
Background:
- Chronic ulcerative colitis (CUC) is associated with an increased risk of colorectal cancer.
- Early detection of dysplasia and cancer in CUC is crucial for patient management.
- Molecular markers can aid in identifying high-risk lesions.
Purpose of the Study:
- To investigate the presence and significance of c-Ki-ras mutations in colonic epithelium of patients with chronic ulcerative colitis.
- To determine if c-Ki-ras mutations correlate with dysplasia and invasive cancer in CUC.
Main Methods:
- A sensitive restriction fragment length polymorphism assay and DNA sequencing were employed.
- Analysis of 56 colonic epithelium specimens from 18 CUC patients.
- Detection of c-Ki-ras mutations at specific codons (12 or 13).
Main Results:
- No c-Ki-ras mutations were found in specimens negative or indefinite for dysplasia.
- Mutations were detected in 4 of 8 patients with high-grade dysplasia.
- Specific c-Ki-ras mutations were identified in dysplastic fields and adjacent invasive cancers.
Conclusions:
- c-Ki-ras mutations are associated with high-grade dysplasia and invasive cancer in chronic ulcerative colitis.
- These mutations can serve as valuable molecular genetic markers for mapping dysplastic fields and cancer.
- Further research may utilize c-Ki-ras mutations for improved surveillance and early diagnosis in CUC.
More Related Videos
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:24Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...